Study of Pazopanib and Pemetrexed in Advanced Non-small Cell Lung Cancer
NCT00871403
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
107
Enrollment
INDUSTRY
Sponsor class
Conditions
Lung Cancer, Non-Small Cell
Interventions
DRUG:
pazopanib and pemetrexed
DRUG:
pemetrexed and cisplatin
Sponsor
GlaxoSmithKline